Thederma
Latest round
- Series A
Last raised
- Oct 2024
Total raised
- $29M
Investors
- 4
About Thederma
Established in 2021 and based in Shanghai, China, Thederma is a company developing innovative drugs for immune-mediated diseases, focusing on the development of therapeutics for autoimmune inflammatory diseases related to AhR targets. The company's CEO, Dr. Geng-Hui Chen, is the co-inventor of the topical drug for the AhR target and personally holds more than 30 pharmaceutical invention patents. The company was rated as a Shanghai Specialized, Refined, Featured and Original SME and a Shanghai Pudong New Area Postdoctoral Innovation and Practice Base. Thederma focuses on the field of immune-mediated diseases, especially the development of drugs for the treatment of autoimmune inflammatory diseases related to the AhR target. The company's drugs can be used to treat diseases of the central nervous system, five sense organs, respiratory and skin diseases. The company generates revenue by developing drugs for the treatment of autoimmune inflammatory diseases related to the AhR target.
Who invested in Thederma
4 investors across 3 rounds
See all investors in Thederma
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Thederma
Who invested in Thederma?
Thederma has 4 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Thederma raised?
Thederma has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Thederma last raise money?
Thederma's most recent round on record is a Series A, in Oct 2024.
What does Thederma do?
Established in 2021 and based in Shanghai, China, Thederma is a company developing innovative drugs for immune-mediated diseases, focusing on the development of therapeutics for autoimmune inflammatory diseases related to AhR targets.
Where is Thederma headquartered?
Thederma is headquartered in Shanghai, China.
Which VCs invest in companies like Thederma?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Thederma's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Thederma? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.